Homes and Property | Home Page

Cyprotex fund-raising plan

13 April 2012

DRUGS testing software group Cyprotex plans to raise funds in the market, new chairman and chief executive Robert Atwater said.

He confirmed Nordan Holdings, a British Virgin Islands company has a 29.9% stake in the Alternative Investment Market-listed group. Half-year operating losses shrank to £1m from £1.4m last time.

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Sign up you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy notice .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in

MORE ABOUT

British Virgin Islands
Caribbean
Investment